Search

Dr. Rudensky studies the development of white blood cells called T lymphocytes, which participate in the immune system response to infection. He joined the Sloan Kettering Institute in 2009.

… Wednesday, September 26, 2012 Summary Dr. Rudensky studies the development of white blood cells called T lymphocytes, which participate in the immune system response to infection. He joined the Sloan Kettering Institute in 2009. Alexander Y. Rudensky has been appointed the new Chair of the Immunology

Leukemia patients may do better on CAR T cell therapy when they are treated early, before their disease relapses.

… Monday, April 3, 2017 Summary For patients with leukemia who relapse after chemotherapy, treatment options have traditionally been limited. At MSK, an experimental immunotherapy called CAR T therapy has expanded options for these patients. New research data presented at this year’s annual meeting of

Memorial Sloan Kettering Cancer Center researchers have published new findings that may help explain why brain tumors called glioblastomas are so resistant to treatment.

… Friday, April 1, 2011 Summary Memorial Sloan Kettering Cancer Center researchers have published new findings that may help explain why brain tumors called glioblastomas are so resistant to treatment. Memorial Sloan Kettering Cancer Center researchers have published new findings that may help explain

A powerful form of MRI could show whether prostate cancer is likely to grow or spread.

… Thursday, September 26, 2019 Summary An imaging method called hyperpolarized MRI can produce highly detailed pictures of a tumor’s metabolic activity. A new study demonstrates that this approach can give clues about whether a prostate cancer is likely to spread, which could guide treatment decisions.

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Wednesday, July 31, 2024 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:  Selwyn Vickers Named to Modern Healthcare’s 2024 50 Most Influential Clinical Executives List Selwyn M. Vickers, MD, FACS Selwyn M. Vickers, MD, FACS , President and CEO, was

Mini Kamboj says encouragement from her family during her early years help mold her into the strong, self-possessed leader needed to guide MSK through the COVID-19 pandemic.

… Monday, March 8, 2021 Summary Mini Kamboj, Chief Medical Epidemiologist since 2014, has led the Infection Control effort at MSK from the beginning of the COVID-19 pandemic, including developing and implementing testing and safety protocols across MSK. Anyone who has met Mini Kamboj knows that she is

Research supports that an inclusive workforce, with diverse leadership, results in better patient care and outcomes. It's known, too, that inclusion leads to greater innovation as the knowledge and ideas of more people, with different perspectives, are brought into the mix.

… Wednesday, August 11, 2021 Research supports that an inclusive workforce with diverse leadership results in better patient care and outcomes. It’s known, too, that inclusion leads to greater innovation as the knowledge and ideas of more people, with different perspectives, are brought into the mix. But

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Thursday, July 15, 2021 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: MSK Leaders Recognized in Crain’s New York Business 2021 Notable in Health Care List Craig B. Thompson, Peter B. Bach, Ushma Neill, and William E. Rosa President & Chief Executive Officer

MSK today announced a $20 million gift from the Ge Li & Ning Zhao Family Foundation to support lung cancer research and the development of new therapies to treat this disease.

… Thursday, May 13, 2021 Memorial Sloan Kettering Cancer Center (MSK) today announced a $20 million gift from the Ge Li & Ning Zhao Family Foundation to support lung cancer research and the development of new therapies to treat this disease. Lung cancer is responsible for 25 percent of all cancer deaths

Memorial Sloan Kettering Cancer Center (MSKCC) is now poised to take greater advantage of a new era in cancer research and education with the opening of a state-of-the-art research center, the establishment of a new graduate school, and the founding of a novel research program in human oncology.

… Monday, September 18, 2006 Memorial Sloan Kettering Cancer Center (MSKCC) is now poised to take greater advantage of a new era in cancer research and education with the opening of a state-of-the-art research center, the establishment of a new graduate school, and the founding of a novel research program